Sleep disorder is associated with increased risk of major adverse cardiovascular events in patients with schizophrenia
- PMID: 40786633
- PMCID: PMC12331771
- DOI: 10.3389/fneur.2025.1601319
Sleep disorder is associated with increased risk of major adverse cardiovascular events in patients with schizophrenia
Abstract
Objective: To evaluate the association of sleep disorder with the risk of major adverse cardiovascular events (MACEs) among patients with schizophrenia-a population known to have heightened cardiometabolic vulnerability, yet underexplored in terms of sleep-related cardiovascular risk.
Methods: The cross-sectional study included 1,072 participants diagnosed with schizophrenia between January and December 2022. The sleep disorder was defined based on self-reported sleep duration, insomnia, and daytime sleepiness, and collected via self-completed questionnaire. Patients' MACEs including fatal and non-fatal myocardial infarction (MI), fatal and non-fatal stroke, and cardiovascular death were collected from chart review. Multivariate logistic regression model was employed to assess the association of sleep disorders with the risk of MACE after controlling for potential confounding factors.
Results: Sleep disorders were common, with 25.7% reporting insomnia, 30.0% reporting short sleep duration (<6 h), and 36.0% experiencing excessive daytime sleepiness. Among the 1,072 patients with schizophrenia, 20.3% experienced a MACE. Participants who have insomnia, short duration of sleep or excessive daytime sleepiness were more likely to have MACEs compared with those without these sleep disorders (all p < 0.01). Multivariate logistic regression indicated that insomnia (OR = 1.88, 95% CI: 1.26-2.78; p < 0.01), short sleep duration (OR = 1.66, 95% CI: 1.17-2. 35; p < 0.01), and excessive daytime sleepiness (OR = 1.55, 95% CI: 1.13-2.12; p < 0.01) were significantly associated with the risk of MACE after controlling for potential confounding factors.
Conclusion: Sleep disorders are significantly associated with a higher risk of MACEs in patients with schizophrenia.
Keywords: MACE; daytime sleepiness; insomnia; schizophrenia; sleep disorder; sleep duration.
Copyright © 2025 Wu, Wang and Jiang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Poor Sleep Quality and Mood Disorders: Risk Factors of Increasing Chronic Pain in Patients with Insomnia.Nat Sci Sleep. 2025 Jun 23;17:1447-1457. doi: 10.2147/NSS.S518518. eCollection 2025. Nat Sci Sleep. 2025. PMID: 40584283 Free PMC article.
-
Pharmacological treatment for central sleep apnoea in adults.Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD012922. doi: 10.1002/14651858.CD012922.pub2. Cochrane Database Syst Rev. 2023. PMID: 36861808 Free PMC article.
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated.
-
Pharmacotherapies for sleep disturbances in Alzheimer's disease.Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178. doi: 10.1002/14651858.CD009178.pub3. PMID: 24659320 Updated.
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
References
-
- Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the global burden of disease (GBD) 2019. Mol Psychiatry. (2023) 28:5319–27. doi: 10.1038/s41380-023-02138-4, PMID: - DOI - PubMed
-
- Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. (2022) 21:248–71. doi: 10.1002/wps.20994, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources